Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dovitinib in Recurrent or Metastatic Adenoid Cystic Carcinoma
NCT01524692Phase 2Completed
- Sponsor
- University of Virginia
- Start
- Mar 2012
- Primary completion
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dovitinib in adenoid cystic carcinoma (ACC), sponsored by University of Virginia. Started Mar 2012; status: completed.
02
Drugs
dovitinib
03
Conditions
adenoid cystic carcinoma (ACC)
Beyond the preview
Go deeper on NCT01524692.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01524692.